Skip to main content

Table 2 Surgical data and pathological factors of the conversion therapy group

From: Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Variable n = 18
Operating procedure
 Total gastrectomy 9(50.0%)
 Distal gastrectomy 9(50.0%)
LN dissection
 D2 14(77.8%)
 D2+ 4(22.2%)
Combined resection
 Spleen 3(16.7%)
 Ovary 7(38.9%)
 Pancreas 1(5.6%)
Operation time (min) 223(157–329)
Blood loss (ml) 150(50–800)
Postoperative complications 6(15.8%)
 pneumonia 3
 anastomotic leakage 1
 abdominal abscess 2
Residual tumor
 CCR-0 15(83.3%)
 CCR-1 3(16.7%)
yp T grade
 T1 3(16.7%)
 T2 5(27.8%)
 T3 2(11.1%)
 T4a 7(38.9%)
 T4b 1(5.6%)
yp N grade
 N0 5(27.8%)
 N1 6(33.3)
 N2 5(27.8%)
 N3 2(11.1%)
Histological response
 G1a 0
 G1b 6(33.3%)
 G2 11(61.1%)
 G3 1(5.6%)
  1. LN Lymph node, CCR completeness of cytoreduction
\